Org. age Ohio . 711 - The Ohio State University

Jones, W. P.; Kinghorn, A. D. Extaction of plant secondary metanolites. In Natural Products Isolation, 2nd
Edit. (Methods of Biotechnology, No. 20); Sarker, S. D., Latif, Z., Gray, A. I., Eds.; Humana Press, Inc.: Totowa,
NJ, 2005, pp. 323-351.
Thomas MJ,; Mameli M,; Carta M,; Valenzuela CF,; Li PK,; Partridge LD. Neurosteroid paradoxical
enhancement of paired-pulse inhibition through paired-pulse facilitation of inhibitory circuits in dentate granule
cells. Neuropharmacology 2005 Mar;48(4):584-96.
Brueggemeier RW, Diaz-Cruz ES. Li PK, Sugimoto Y, Lin YC, Shapiro CL. Translational studies on aromatase,
cyclooxygenases, and enzyme inhibitors in breast cancer. J Steroid Biochem Mol Biol. 2005 May;95(1-5):129-36.
Li, P. K.; Xiao, Z.; Hu, Z.; Pandit, B.; Sun, Y.; Sackett, D. L.; Werbovetz, K.; Lewis, A.; Johnsamuel, J
Conformationally restricted analogs of Combretastatin A-4 derived from SU5416 Bioorg Med Chem Lett 2005,
15, (24), 5382-5.
Byun, Y.; Yan, J.; Al-Madhoun, A.S.; Johnsamuel, J.; Yang, W.; Barth, R.F.; Eriksson; S.; Tjarks, W.; Synthesis
and Biological Evaluation of Neutral and Zwitterionic 3- Carboranyl Thymidine Analogues for Boron Neutron
Capture Therapy; J. Med. Chem. 48, 1188-1198, 2005.
Bandyopadhyaya, A.K.; Johnsamuel, J.; Al-Madhoun, A.S.; Eriksson; S.; Tjarks, W.; Comparative Molecular Field
Analysis and Comparative Molecular Similarity Indices Analysis of Human Thymidine Kinase 1 Substrates;
Bioorg. Med. Chem., 13, 1681-1689, 2005.
Johnsamuel, J.; Eriksson, E.; Oliveira, M.; Tjarks, W.; Docking simulation with a purine nucleoside specific
homology model of deoxycytidine kinase, a target enzyme for anticancer and antiviral therapy; Bioorg. Med.
Chem., 13, 4160-4167, 2005.
Backer, M.V.; Gaynutdinov, T.I.; Patel, V.; Bandyopadhyaya, A.K.; Thirumamagal, B.T.S.; Tjarks, W.; Barth,
R.F.; Claffey, K.; Backer, J.M.; Vascular endothelial growth factor selectively targets boronated dendrimers to
tumor vasculature, Molecular Cancer Therapeutics, 4, 1423-1429, 2005.
M. Salem and K. Werbovetz. Antiprotozoal compounds from Psorothamnus polydenius, Journal of Natural
Products, 68: 108-111, 2005.
G. Bhattacharya, L. Gerena, S. Jiang, and K. Werbovetz. Activity of amidine-containing diphenylureas against P.
falciparum, Letters in Drug Design & Discovery, 2: 162-164, 2005.
P. Li, Z. Xiao, Z. Hu, B. Pandit, Y. Sun, D. Sackett, K. Werbovetz, A. Lewis, J. Johnsamuel. Conformationally
restricted analogs of Combretastatin A-4 derived from SU5416, Bioorganic and Medicinal Chemistry Letters, 15:
5382-5385, 2005.
2005 Division of Pharmaceutics
Wei, Y. and Au, J.L.-S. Role of tumor microenvironment in mediating chemoresistance. In: Cancer Growth and
Progression. In: Integration/Interaction of Oncologic Growth. (Meadows, G., ed). Kluwer Academic Publishers.
2005. Vol. 15, pp. 285-321, 2005.
Wei, Y. and Au, J.L.-S. Role of tumor microenvironment in mediating chemoresistance. In: Cancer Growth and
Progression. In: Integration/Interaction of Oncologic Growth. (Meadows, G., ed). Kluwer Academic Publishers.
2005. Vol. 15, pp. 285-321, 2005.
Au, J.L.-S., and Wientjes, M.G. Intravesical chemotherapy of superficial bladder cancer: optimization and novel
agents. In: Textbook on bladder cancer. Lerner, S., Schoenberg, M.P., and Sternberg, C., eds., Martin Dunitz
Publishers, 2006, pp. 341-352.
Marcucci G, Stock W, Dai G, Klisovic RB, Liu S, Klisovic MI, Blum W, Kefauver C, Sher DA, Green M,
Moranm M, Maharry K, Novic B, Zwiebel JA, Larson RA, Grever MR, Chan KK, and Byrd JC. Phase I Study of
Oblimersen Sodium, an Antisense to Bcl-2, in Untreated Older Patients with Acute Myeloid Leukemia:
Pharmacokinetics, Pharmacodynamics and Clinical Activity. J of Clin Oncology, 23 (15): 3404-3411, 2005.
39